Background: Abdominal obesity plays an important role in the development of insulin resistance, diabetes mellitus and atherosclerosis. The exact pathophysiological mechanisms are unclear but adipocyte dysfunction is thought to be crucial. Infections are associated with the development of atherosclerosis as well as diabetes. In this study we investigated whether adipocytes can be infected and whether this results in production of inflammatory cytokines relevant for the development of atherosclerosis and diabetes. Methods: Pre-adipocytes were cultured and differentiated into mature adipocytes in vitro. Adipocytes and pre-adipocytes were incubated with infective and heat-inactivated Chlamydia pneumoniae, cytomegalovirus (CMV), adenovirus (Ad) subtypes 2 and 36, influenza A and respiratory syncitial virus (RSV). After 48 h, adiponectin, interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a) and plasminogen activator inhibitor-1 (PAI-1) were measured in supernatants. Results: Infection of adipocytes with Ad-36, CMV and RSV resulted in increased IL-6 production from 192 ± 22 pg ml À1 (uninfected) to 1030 ± 86 pg ml À1 , 838 ± 59 pg ml À1 and 1241 ± 191 pg ml À1 , respectively (all Po0.01 vs control). In addition, Ad-36 infection slightly reduced PAI production in adipocytes (285 ± 26.8 ng ml À1 vs uninfected: 477 ± 71.2 ng ml À1 ; P ¼ 0.05) and pre-adipocytes (709±43.3 ng ml À1 vs uninfected: 1071±71.8 ng ml À1 ; Po0.01). In contrast, human Ad type 2 did not exert any effect on IL-6 or PAI production. None of the microorganisms induced significant changes in adiponectin and/or TNF-a production. Conclusions: Adipocytes can be infected with several microorganisms in vitro. Infection of adipocytes with Ad-36, but not Ad-2 leads to increased production of IL-6 which might contribute to chronic low-grade inflammation, a process known to be involved in the development of cardiovascular diseases and type 2 diabetes.
Introduction
Obese patients have an increased risk for the development of atherosclerosis, type 2 diabetes mellitus and myocardial infarction. 1 Although the exact pathophysiological mechanisms are not yet clear, insulin resistance, closely related with obesity, and inflammation are key components. 2, 3 Abdominal adipose tissue not only absorbs and stores free fatty acids, but is also able to produce and secrete adipokines such as interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a), plasminogen activator inhibitor-1 (PAI-1) and adiponectin.
By producing hormones and inflammatory cytokines, adipose tissue is likely to play an important role in the development of diabetes and atherosclerosis. [4] [5] [6] [7] Adipocyte dysfunction can be the cause but also the consequence of insulin resistance. Causes for adipocyte dysfunction are not well established but include abdominal obesity and elevated free fatty acid plasma concentration. 8 Cytomegalovirus (CMV) and Chlamydia pneumoniae (Cp) are thought to be involved in the pathogenesis of atherosclerosis and cardiovascular disorders. [9] [10] [11] [12] [13] [14] It has been shown before that adenoviruses (Ad) are able to infect adipocytes 15, 16 and that this is possibly related to the development of obesity. 17, 18 Data from studies in animals indicate a possible role for virus infections in the etiology of human obesity. [19] [20] [21] Moreover, Ad-36 is associated with increased body weight and paradoxically lower cholesterol and triglyceride levels in Ad-36 antibody-positive vs -negative subjects. 22 Therefore it can be hypothesized that (chronic) virus infections induce adipocyte dysfunction thus leading to the development of diabetes mellitus and/or cardiovascular diseases.
In the present study we investigated whether several viruses are able to infect adipocytes in vitro and whether this leads to adipocyte dysfunction as measured by the altered production of IL-6, TNF-a, adiponectin and PAI-1.
Methods

Culturing of adipocytes
Cryopreserved human subcutaneous pre-adipocytes from an obese donor (body mass index430; SP-F3 passage 2; ZenBio Inc., Tebu Bio BV, Heerhugowaard, The Netherlands) were cultured in pre-adipocyte medium (PM- After propagation on the appropriate cell lines in tissue culture bottles, the upscaled inoculation materials were harvested, aliquoted and subsequently frozen at À80 1C.
Infective doses (TCID 50 ) of each isolate were determined using corresponding cell lines according to the method of Reed and Muench. 23 As infection controls for the main experiments, aliquots of all isolates were inactivated using one standard procedure: incubation at 56 1C for 1 h followed by overnight UV irradiation. Effectiveness of the inactivation procedure was checked by incubating undiluted inactivated isolates on the cell lines on which they were propagated initially for 48 h.
Infection experiments
Cultures with more than 75% differentiated adipocytes were infected 13-15 days after the start of the differentiation. For each inoculation of cultures with differentiated adipocytes, cultures with pre-adipocytes were inoculated simultaneously. Infection rates were determined by calculating the number of infectious virus per cell. This was expressed as the multiplication of infection (MOI). For each inoculation with infective virus, inactivated virus was inoculated as an infection control. As a negative control, cells were incubated with culture medium only. All incubations were monitored by the corresponding immunofluorescent staining for each virus type. Optimal infection rates for the main experiments were determined in preliminary infection experiments with serial dilutions of each stock (data not shown). The rationale for using fairly low MOIs was to mimic chronic infection in vivo and to avoid unwanted cell death. Therefore infection rates of maximum 25% (fluorescence) were chosen. Prior to infection, adipocytes were refed with fresh AM and pre-adipocytes with PM. Adipocytes and pre-adipocytes were inoculated with 200 ml of both infective and inactivated virus; MOIs were 0.01 and 0.001 for CMV, Ad2 and Ad-36 and MOI 0.02 and 0.002 for Cp, influenza and RSV.
In addition to the infections, the ability of cells to produce adipokines was measured by incubating the cells with 1 or 10 ng ml À1 IL-1b or IL-6 or 100 mg ml À1 TNF-a.
All experiments were performed three times in duplicate on cells at passage 4, grown in 24-well plates. After inoculation, plates were centrifuged 1 h at 500 g. All incubations were kept for 48 h at 37 1C and 5% CO 2 . After 48 h IL-6 production by infected adipocytes JJM Bouwman et al supernatants were collected and frozen at À80 1C until adipokines were measured. Infections and incubations with inactivated virus were checked by immunofluorescence.
Measurement of adipokines
Commercially available ELISA kits were used for measuring IL-6 (Pelikine compact human IL-6 kit, no. M1916; Sanguin Reagents, the Netherlands), (Pelikine compact human TNF-a kit, no. M1923; Sanguin Reagents), PAI (PAI-1 antigen Elisa reagent kit, no. TC11070; Technoclone GmbH Vienna, Austria) and adiponectin (human adiponectin/Acrp30 ELISA kit, (no. ELH-ACRP30-001; RayBiotech Inc., Norcross GA, USA). All assays were performed three times in duplicate. Optical densities were measured with an automated plate reader (Elx800, Biotek Instruments Inc.) at 450/630 nm and data were processed in analytical curve fitting software (KC Junior, Biotek instruments Inc.).
Statistical analysis
Enzyme-linked immunosorbent assay results were processed using the GraphPad Instat statistical software package (V2.05a). After infection, adipokine levels in the supernatants of infected adipocytes were compared with those in pre-adipocytes and in uninfected control cells or cells incubated with inactivated virus. In addition, adipokine production after incubation with IL-1b, IL-6 or TNF-a was compared to the adipokine levels in uninfected cells. An unpaired Student's t-test was performed on all results unless standard errors of means were significantly different (Po0.05). On those results where standard errors of means did differ, a Welch's t-test, correcting for these differences was performed.
Results
(Pre-)Adipocyte culture After seeding in 24-well plates, cultured pre-adipocytes (passage 4) needed 3-5 days to grow to confluence (Figure 1a) . During differentiation cells transformed from spindle-shaped 'fibroblast-like' to more rounded cells, which accumulated lipid droplets in their cytoplasm (Figure 1b) . The differentiation grade was at least 75% after 13 days.
IL-6 production by uninfected pre-adipocytes and adipocytes During the differentiation process, adiponectin production increased from 159±155 pg ml À1 at day 0 (start of differentiation) to 259 ± 110 pg ml À1 on day 3 and 8972 ± 3228 pg ml À1 on day 7. Pre-adipocytes did not produce adiponectin at all. The IL-6 production by uninfected adipocytes decreased from 3058±550 pg ml À1 at day 0 (start of differentiation) to 1433 ± 485 pg ml À1 (day 3), 1146 ± 285 pg ml À1 (day 7) and 71 ± 32 pg ml À1 (day 9) and increased from day 13:
) to day 15: (177±24 pg ml
À1
) and day 19 (257 ± 57 pg ml
). IL-6 production in pre-adipocytes remained at the same level as was measured at the start of the differentiation phase.
Virus infection of adipocytes
All viruses (CMV, Ad2, Ad-36, influenza A (Inf A), RSV) and Cp were able to infect adipocytes in vitro (Figures 2a-f ). However, there was not a IL-6 production by infected adipocytes JJM Bouwman et al significant difference between IL-6 production by heat-inactivated an infective Ad36 (P ¼ 0.08). After incubation with lower doses of A36, IL-6 levels in adipocytes were not elevated anymore (Po0.05). Therefore the effect was considered to be virus dose-dependent. In contrast to the clearly elevated IL-6 production by Ad-36, IL-6 production in Ad2-infected adipocytes was not affected (171 ± 30 pg ml
À1
; P40.05). Compared to uninfected adipocytes, infection of adipocytes with CMV or RSV also induced significant increase in IL-6 production (838±59 and 1241±191 pg ml
, respectively vs uninfected adipocytes (192 ± 22 pg ml À1 ; Po0.01) (Figure 3a) .
Baseline production of IL-6 by pre-adipocytes was considerably higher than in adipocytes (5234 ± 837 vs 192 ± 22 pg ml À1 ) but quite similar to infected adipocytes;
infection of pre-adipocytes with Ad36 or RSV resulted in a more than twofold increase in IL-6 from baseline (10957 ± 1945 pg ml À1 (Po0.05) and 12079 ± 2302 pg ml À1 (Po0.01), respectively vs 5234 ± 837 pg ml À1 in uninfected cells). CMV infection did not lead to elevated IL-6 production by pre-adipocytes (Figure 3b) . Mean TNF-a productions of uninfected adipocytes and pre-adipocytes were 52.9±3.9 and 55.4±11.3 pg ml
, respectively as measured after 15 days of incubation. None of the microorganisms were able to increase TNF-a secretion by adipocytes (Figure 4a ). In contrast, pre-adipocytes infected with the highest doses of Ad-36, CMV and RS-virus produced approximately twofold more TNF-a than (Figure 4b ). Only incubation with the highest infective dose of Ad36 led to decreased PAI-1 production in pre-adipocytes (709±43.3 ng ml
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À1
), compared to uninfected pre-adipocytes (1071±71.8 ng ml À1 ; Po0.01) but not in adipocytes:
285 ± 26.8 ng ml
; P ¼ 0.05 vs 477 ± 71.2 ng ml À1 in uninfected adipocytes. None of the other microorganisms affected PAI production (Figures 5a and b) . After 48 h, the adiponectin production by uninfected adipocytes was 9325 ± 3029 pg ml
. Compared to adiponectin production by uninfected adipocytes, the adiponectin production by adipocytes that were incubated with either infective or inactivated microorganisms tended to decrease. (Overall -35%; Cp -37%, CMV -52%, Ad2 -30%, Ad-36 -30%, Inf A -26%, RSV -36%). This effect, however, was not statistically significant ( Figure 6 ). Pre-adipocytes did not produce adiponectin at all (data not shown). indicates IL-6 production in adipocytes incubated with infective microorganisms.
indicates IL-6 production in adipocytes incubated with inactivated microorganisms. IL-6 production in pg ml À1 (y axis), microorganisms used for incubations with corresponding MOI (multiplication of infection) values (x axis), uninfected cells (baseline); Cp, Chlamydia pneumoniae; CMV, cytomegalovirus; Ad, adenovirus; Inf, influenza A virus; RSV, respiratory syncytial virus; *Po0.01 (t-test). (b) IL-6 production in infected preadipocytes. Means ± s.e. values of three experiments in duplicate (n ¼ 3). indicates IL-6 production in pre-adipocytes incubated with infective microorganisms. indicates IL-6 production in pre-adipocytes incubated with inactivated microorganisms. IL-6 production in pg ml À1 (y axis), microorganisms used for incubations with corresponding MOI (multiplication of infection) values (x axis), uninfected cells (baseline); Cp, Chlamydia pneumoniae; CMV, cytomegalovirus; Ad, adenovirus; Inf, influenza A virus; RSV, respiratory syncytial virus; *Po0.01, **Po0.05 (t-test).
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Discussion
The present study shows that various microorganisms are able to infect adipocytes in vitro. Adipocyte infection resulted in an increased production of IL-6. Ad infection of pre-adipocytes leads to altered PAI-1 production. These results can be viewed in the context of involvement of adipocytes in the pathogenesis of cardiovascular diseases and in relation with the development of diabetes mellitus. Compared with endothelial cells, 9,13 monocytes 10 and hepatocytes, 24 adipocytes react in a similar way to infection with a variety of microorganisms by producing inflammatory cytokines. Abdominal adipose tissue was thought to be just a storage depot for fat, but is now considered to be an active endocrine organ able to produce several hormones and inflammatory cytokines. These hormones and inflammatory cytokines have systemic effects on the vessel wall, vascular risk factors and on insulin resistance. By the portal circulation, these hormones and inflammatory cytokines are also able to directly influence liver metabolism, potentially leading to accelerated inflammatory response, for example, C-reactive protein (CRP) production, and leading to changes in hemostasis by the production of coagulant factors and proteins involved in fibrinolysis. Specific causes for changes in adipocyte function are not well known. We propose a role for microorganisms in inducing and maintaining adipocyte dysfunction. At present, it is commonly accepted that (chronic) inflammation plays a key role in atherogenesis and athero- indicates TNF-a production in adipocytes incubated with infective microorganisms.
indicates TNF-a production in adipocytes incubated with inactivated microorganisms. TNF-a production in pg ml À1 (y axis), microorganisms used for incubations with corresponding MOI (multiplication of infection) values (x axis), uninfected cells (baseline);
Cp, Chlamydia pneumoniae; CMV, cytomegalovirus; Ad, adenovirus; Inf A, influenza A virus; RSV, respiratory syncytial virus. (b) TNF-a production in infected preadipocytes. Means ± s.e. values of three experiments in duplicate (n ¼ 3). indicates TNF-a production in pre-adipocytes incubated with infective microorganisms. indicates TNF-a production in pre-adipocytes incubated with inactivated microorganisms. TNF-a production in pg ml À1 (y axis), microorganisms used for incubations with corresponding MOI (multiplication of infection) values (x axis), uninfected cells (baseline); Cp, Chlamydia pneumoniae; CMV, cytomegalovirus; Ad, adenovirus; Inf, influenza A virus; RSV, respiratory syncytial virus.
IL-6 production by infected adipocytes JJM Bouwman et al sclerosis. [25] [26] [27] Elevated plasma concentrations of CRP are associated with increased cardiovascular risk and are seen in patients with obesity, metabolic syndrome or type 2 diabetes. [28] [29] [30] Microorganisms are thought to play a role in the development of atherosclerosis 31, 32 although treatment of Cp with antibiotics did not lead to a reduction in the occurrence of vascular events. 33 The absence of an effect of antibiotic treatment on vascular events may be due to ineffective treatment strategies not affecting Cp in circulating monocytes. 34 Also, it can still be argued that viral infections, not affected by macrolide treatment, are involved in atherogenesis, arterial thrombosis and plaque rupture. 35, 36 Recently, Ad infections were considered to play a role in the development of obesity and are associated with plasma lipid abnormalities. 15, 17, 18, 37, 38 In the present study it is shown that a range of different viral and bacterial microorganisms are able to infect human adipocytes and induce an inflammatory response. The production of IL-6 by adipocytes increased in a dose-and infection-dependent manner.
Circulating TNF-a and IL-6 plasma concentrations are mildly elevated in obesity. Both TNF-a and IL-6 modify insulin sensitivity by interfering with intracellular insulin signaling pathways. 39 The production of TNF-a and IL-6 by infected abdominal adipocytes and their release into the indicates PAI-1 production in pre-adipocytes incubated with infective microorganisms.
indicates PAI-1 production in pre-adipocytes incubated with inactivated microorganisms. PAI-1 production in ng ml À 1 (y axis), microorganisms used for incubations with corresponding MOI (multiplication of infection) values (x axis), uninfected cells (baseline); Cp, Chlamydia pneumoniae; CMV, cytomegalovirus; Ad, adenovirus; Inf, influenza A virus; RSV, respiratory syncytial virus; *Po0.05 (t-test).
IL-6 production by infected adipocytes JJM Bouwman et al portal circulation may lead to increased production of CRP by the liver and influence lipid metabolism leading to an increased cardiovascular risk 40, 41 and increased risk for the development of type 2 diabetes. 42, 43 The inflammatory response of adipocytes upon infection may also have paracrine effects by affecting the function of neighboring adipocytes and may attract macrophages into adipose tissue, increasing the capacity for the production of inflammatory mediators. The production of the proinflammatory cytokines IL-6, TNF-a and monocyte chemotactic protein-1 (MCP-1) is upregulated in a co-culture with 3T3-L1 adipocytes and a macrophage cell line RAW264. 44 It has been suggested that one-third of circulating plasma IL-6 is secreted by adipose tissue 45, 46 reaching systemic concentrations high enough to elicit biological effects. 47, 48 Adenoviruses were the first pathogens associated with human obesity. SMAM-1 was the first (avian) Ad described to be positively related to obesity, 37 and Ad36 was the major adenovirus subtype reported to enhance adipocyte differentiation and having an association with obesity. 15, 37 The human adenovirus types 5, 31 and 37 also appear to increase pre-adipocyte differentiation, although their association with obesity is still unclear. 16, 22, 38 In the present study we showed that the Ad36 virus was able to increase IL-6 production by pre-adipocytes and adipocytes. Interestingly, the Ad2 subtype did not exert any functional effects on (pre-)adipocytes, indicating a specific mechanism of action in adipocyte signaling for the Ad36 virus type. It has been suggested that enhanced differentiation of cultured pre-adipocytes by Ad36, but not Ad2, may contribute to adipogenesis 49, 50 This would implicate that Ad-36
is associated with increased body weight. This was confirmed by showing that the antiviral agent cidofovir attenuated differentiation induced by Ad-36 through altering gene expression in adenovirus-infected 3T3-L1 cells. 49 In mice, treatment with cidofovir significantly suppressed plasma IL-6 concentrations after intraperitoneal infection with cowpox. 51 Still, it remains unclear whether reduction of IL-6 concentrations by cidofovir treatment also leads to subsequent weight loss. We acknowledge some limitations of the present study. For all experiments a stable culture of human subcutaneous cells from one obese donor was used. This culture was not continuous. It is not known whether the results from these adipocytes can be extrapolated to cells derived from other donors and from different body depots. Adipocytes beyond passage 4 had a reduced capacity for differentiation and had changed capacity for producing adipokines. This indicates that adipocyte cultures are very sensitive to functional changes. In our experiments a differentiation grade of approximately 75% was reached. Not reaching full differentiation was not considered to be an issue because adipose tissue in vivo consists of 30-60% adipocytes. Others already suggested differences in the capacity of adipokine production by pre-adipocytes compared to mature adipocytes. [52] [53] [54] We demonstrated that adiponectin was mainly produced by adipocytes, while IL-6 and PAI were produced by both adipocytes and pre-adipocytes, but pre-adipocytes produced more IL-6 and PAI than adipocytes.
In conclusion, various microorganisms are able to infect human adipocytes in vitro. Infection of adipocytes elicited increased IL-6 production. This pro-inflammatory effect of adipocyte infection may contribute to the development of cardiovascular diseases and/or the development of diabetes mellitus. indicates adiponectin production in adipocytes incubated with infective microorganisms.
indicates adiponectin production in adipocytes incubated with inactivated microorganisms. Adiponectin production in pg ml À1 after log transformation (y axis), microorganisms used for incubations with corresponding MOI (multiplication of infection) values (x axis), uninfected cells (baseline); Cp, Chlamydia pneumoniae; CMV, cytomegalovirus; Ad, adenovirus; Inf, influenza A virus; RSV, respiratory syncytial virus.
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